Hayley French

Apitope Technology (Bristol) Ltd. is a European biotech company developing therapeutic vaccines for treating autoimmune and allergic diseases, including multiple sclerosis, Type 1 diabetes, Graves' disease, allergies and organ transplant rejection. The team at Apitope is developing potential therapies intended to selectively treat the underlying cause of a range of autoimmune diseases rather than simply treat the disease symptoms or non-specifically suppress the whole immune system. Apitope's approach is based on well-established scientific evidence published in leading scientific journals showing that soluble, synthetic peptides can selectively suppress abnormal immune responses and reinstate the normal immune balance and thereby, tolerance. The firm's strategy is to position itself as a significant player in the therapeutic peptide space and make it a partner of choice for pharmaceutical companies keen to develop disease modifiers for autoimmune conditions. It has a highly experienced senior management team, with a proven track record in discovering and developing innovative compounds. The company's lead product candidate is under investigation for the potential treatment of multiple sclerosis and is currently in Phase I clinical development. It is partnered with Merck-Serono (a division of Merck KGaA, Darmstadt, Germany), one of the leading companies in the development and marketing of MS therapies.

Arix Capital Management Ltd (Arix Capital Management) is a venture capital subsidiary of Arix Bioscience Plc founded in 2012 by Christopher Thomas Evans. The firm is headquartered in Cardiff, United Kingdom.

CeQur SA develops medical devices for diabetes patients. It offers n insulin delivery device that provides three days of consistent, basal insulin deliver along with on-demand bolus insulin. The company was founded by James L. Peterson in January 2008 and is headquartered in Horw, Switzerland.

Simbec-Orion Group Ltd. provides contract research services for rare and orphan conditions. The firm offers services for oncology, orphan diseases, respiratory, dermatology, infectious vaccines and diseases. The company was founded in 2014 and is headquartered in Pentrebach, the United Kingdom.

The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members.

Sphere Medical Ltd. develops monitoring and diagnostic products to provide clinical and economic benefits in critical care environment. It offers microfabricated and transducers technologies. The company was founded in March 2002 by Gavin Troughton and is headquartered in Cambridge, the United Kingdom.

Sanan Capital Ltd. provides investment services. The private company is based in Dinas Powys, UK. It was founded in 2019.

The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom.

Nascom NV engages in the creation dof digital products and solutions. It offers electronic-commerce, business, mobile applications business strategy, user experience design, brand design, and webdesign services. Nascom was founded by Jonas Jan Martijn Coenen in 2003 and is headquartered in Genk, Belgium.

WestBridge Fund Managers Ltd. (WestBridge Fund Managers) is an independent private equity arm of WestBridge Capital LLP founded in 1994 by Guy Davies, James Wakefield and Valerie Kendall. The firm is headquartered in Mayfair, London with additional offices in Manchester and Cardiff.

Limburgse Reconversie Maatschappij NV (LRM) is an independent private equity firm which was founded in 1994 by the Flemish government. Limburgse Reconversie Maatschappij NV is headquartered in Hasselt, Beglium.

TrendMiner NV provides data mining software and solutions. Its product TrendMiner delivers discovery, diagnostic and predictive analytics with real time monitoring tools for the process industry. The company was founded by Bart De Moor, Thomas Dhollander, Noel Jans, Bert Baeck, Tom Coen and Anthony Devney in December 2007 and is headquartered in Hasselt, Belgium.

C-Mine Crib NV operates a creative hub. It has a college that offers artistic graduation programs, an incubator for young entrepreneurs, a cultural center, a design center, and a cinema. The firm supports starting and young creative companies in their start-up and development by offering specialized guidance, coaching, and accommodations. The company was founded in 2005 and is headquartered in Genk, Belgium.

Silicon Line GmbH designs and manufactures analog and mixed signal integrated circuits. Its products include VCSEL driver/TIA, serializer/De-serializer and modules. The company was founded by Holger Hoeltke and Martin Groepl in 2005 and is headquartered in Munich, Germany.

Cegeka NV engages in the provision of information and communication technology solutions. It offers cloud, software, outsourcing, business process, digital experience, data and automation, and training services. The firm servers the agriculture, food, energy, utilities, manufacturing, retail, leisure, aviation, mobility, healthcare, and telecom industries. The company was founded by André Knaepen in 1992 and is headquartered in Hasselt, Belgium.

Laser Cladding Venture NV manufactures laser cladding, laser metal deposition, and related products. Its services with laser cladding include coating, three-dimensional (3D) printing, tool repair, and hardening. The company was founded by Jan Gabriel Jozef Maria Lambrecht on August 31, 2015 and is headquartered in Opglabbeek, Belgium.

Soulco NV provides business process translation and acceleration software solutions. It distributes and integrates IT and telecom products and services. The company was founded in 2001 and is headquartered in Beringen, Belgium.

Limburg Regional Airport BVBA operates as an airport. The company is headquartered in Genk, Belgium.

Corda Incubator provides incubator services. The company offers professional training and coaching services. Corda Incubator is headquartered in Hasselt, Belgium.

UgenTec NV develops laboratory software. The firm delivers an independent diagnostic platform to help molecular labs with DNA (PCR) analyses. The company was founded by Tom Martens and Wouter Uten on April 30, 2014 and is headquartered in Hasselt, Belgium.

Excalibur Fund Managers Ltd (Excalibur) is a venture capital firm founded in 1996 by Christopher Evans. The firm is headquartered in London, United Kingdom.

Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands.

Part of Vesalius Biocapital Partners SARL, Vesalius Biocapital I Investments SA SICAR is a venture capital fund. The company is based in Luxembourg, Luxembourg.

Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.

Vesalius Biocapital Partners SARL (Vesalius Biocapital Partners) is an independent venture capital firm founded in 2007 by Stéphane Verdood. The firm is headquartered in Luxembourg.

Value For Growth NV provides independent consulting and coaching services. The private company is based in Tervuren, Belgium. The Belgian company was founded by Gaston Mattyssens, Stéphane Verdood.

Trod Medical NV develops and commercializes tools for use in the focal ablation of soft tissues. The company was founded by Andre Scattolin Faure on June 29, 2006 and is headquartered in Leuven, Belgium.

Biotechnological Enzymatic Catalyse NV develops, produces and commercializes enzymatic systems for food preservation. It engages in the research, development and manufacturing of antimicrobial products for food safety. The firm's solutions are designed for use in the following: dairy products, fruit and vegetable juices, sauces and dressings and liquid egg products. The company was founded in 1992 and is headquartered in Ghent, Belgium.

Fast Forward Pharmaceuticals BV develops novel disease-modifying therapeutics for the treatment of inflammatory and autoimmune diseases. It is developing an anti-CD40 monoclonal antibody therapy for the treatment of chronic inflammatory diseases like primary biliary cirrhosis and Crohn’s disease. The company was founded by Louis Boon in October 2010 and is headquartered in Utrecht, Netherlands.

Part of Ernst & Young Global Ltd., Arthur Andersen /Belgium/ is a Belgian company that provides accounting services. The company is located in Belgium. The company was founded by Stéphane Verdood. Arthur Andersen /Belgium was acquired by Deloitte & Touche LLP from Arthur Andersen LLP on April 18, 2002.

Vesalius Biocapital I SA Sicar focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project.

Vesalius Biocapital Arkiv NV focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project. Vesalius Biocapital Arkiv is part of the ARKImedes project which, is organized and/or managed by Participatiemaatschapij Vlaanderen NV.

Vesalius Biocapital II Arkiv NV focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project. Vesalius Biocapital Arkiv is part of the ARKImedes project, which is organized and/or managed by Participatiemaatschapij Vlaanderen NV.